claims
NAD Finds Certain Claims for OLLY’s Lovin’ Libido Supplement Supported, But Not All
In a challenge brought by competitor Bayer Healthcare LLC (Whippany, NJ), BBB National Programs’ National Advertising Division (NAD) determined that Olly PBC (San Francisco, CA) provided a reasonable basis for claims made for its Lovin’ Libido dietary supplement related to desire, drive, arousal, satisfaction and lubrication. However, NAD recommended that Olly discontinue its Lovin’ Libido ...
Checking on Supplements: NAD’s Recent Guidance on Substantiating Ingredient vs. Product Claims
Imagine a breakthrough dietary supplement that solves all your problems—you’ll lose weight, feel calm and relaxed, reduce bloating, sleep better, wake up happier and have more energy. Sound too good to be true? Maybe. But what if studies show that the ingredients in the supplement each support those claims—would that be false advertising? On Aug. ...
Clinical Research & Natural Ingredients
The panel: William A. Chioffi, COO, Nammex, Calgary, AB, Canada and Asheville, NC, www.nammex.com Nena Dockery, Scientific Affairs Manager, Stratum Nutrition, Carthage, MO, https://stratumnutrition.com Annie Eng, CEO, HP Ingredients, Bradenton, FL, https://hpingredients.com Shaheen Majeed, Global CEO & Managing Director, Sabinsa, Salt Lake City, UT, https://sami-sabinsagroup.com James Roza, Chief Scientific Officer, Layn Natural Ingredients, Irvine, CA, ...
Aggressively Defending the Baseless Class Action
By all accounts, consumer class action filings have dramatically increased over the past few years. And for every class action that gets filed, there are dozens, if not hundreds, of threatened claims. Most threatened claims are confidentially settled individually on an out-of-court basis, with little regard to the strength or weakness of the claims being ...
FDA Announces Qualified Health Claim for Magnesium and Reduced Risk of High Blood Pressure
In a letter of enforcement discretion released on Jan 10., the U.S. Food and Drug Administration (FDA) announced that it does not intend to object to the use of certain qualified health claims regarding the consumption of magnesium and a reduced risk of high blood pressure (hypertension), provided that the claims are appropriately worded to avoid misleading ...
FTC Complaint Against Quincy Bioscience Dismissed
On September 29, Judge Louis Stanton of the U.S. District Court in the Southern District of New York dismissed the Federal Trade Commission (FTC) and the New York Attorney General’s (NYAG) complaint against Wisconsin-based Quincy Bioscience, the makers of Prevagen. In January, the FTC and the NYAG charged the marketers of the dietary supplement Prevagen with making ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Nutrition Industry Executive magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
Featured Listings:
